Lab urges FDA to suspend ranitidine sales due to degradation risk 13-Jan-2020 By Nick Taylor Emery Pharma files citizen petition arguing data on the degradation of ranitidine supports suspension of the medicine.
Sanofi and Dr Reddy’s join the ranitidine recall 24-Oct-2019 By Ben Hargreaves Both companies issue a voluntary recall of their ranitidine-based products due to the ongoing investigation into cancer-causing contamination.
Further NDMA contamination discovery prompts lawsuit 17-Sep-2019 By Ben Hargreaves Both the FDA and EMA announce NDMA contamination of ranitidine medicines and a lawsuit is immediately filed against manufacturers for ‘concealing’ the carcinogen.